(Q34529430)

2 August 2017

1 reference

title

FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review (English)

1 reference

2 August 2017

1 reference

Uhl EW

1

1 reference

2 August 2017

Heaton-Jones TG

series ordinal

2

1 reference

2 August 2017

Pu R

series ordinal

3

1 reference

2 August 2017

Yamamoto JK

series ordinal

4

1 reference

2 August 2017

language of work or name

1 reference

1 December 2002

1 reference

Veterinary Immunology and Immunopathology

2 August 2017

1 reference

2 August 2017

90

1 reference

2 August 2017

3-4

1 reference

2 August 2017

113-132

1 reference

Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification.

2 August 2017

1 reference

12 December 2020

Relationship of lymphoid lesions to disease course in mucosal feline immunodeficiency virus type C infection

1 reference

12 December 2020

Clinical and pathological findings in feline immunodeficiency virus experimental infection

1 reference

12 December 2020

Progress in HIV vaccine development

1 reference

12 December 2020

Challenges and opportunities for development of an AIDS vaccine

1 reference

12 December 2020

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: reevaluation of neutralizing antibody levels elicited by a protective and a nonprotective vaccine after removal of antisubstrate cell antibodies

1 reference

12 December 2020

New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview

1 reference

12 December 2020

Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.

1 reference

12 December 2020

Persistence of high virus neutralizing antibody titers in cats experimentally infected with feline immunodeficiency virus

1 reference

12 December 2020

Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.

1 reference

12 December 2020

Effect of dual-subtype vaccine against feline immunodeficiency virus infection

1 reference

12 December 2020

Virulence differences between two field isolates of feline immunodeficiency virus (FIV-APetaluma and FIV-CPGammar) in young adult specific pathogen free cats

1 reference

12 December 2020

NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection

1 reference

12 December 2020

Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted.

1 reference

12 December 2020

The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages

1 reference

12 December 2020

Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates

1 reference

12 December 2020

New approaches to the development of virus vaccines for veterinary use.

1 reference

12 December 2020

Parameters of disease progression in long-term experimental feline retrovirus (feline immunodeficiency virus and feline leukemia virus) infections: hematology, clinical chemistry, and lymphocyte subsets.

1 reference

12 December 2020

Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus

1 reference

12 December 2020

World Wide Web-based survey of vaccination practices, postvaccinal reactions, and vaccine site-associated sarcomas in cats

1 reference

12 December 2020

Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route

1 reference

12 December 2020

Clinical and laboratory findings in cats infected with feline immunodeficiency virus

1 reference

12 December 2020

Mucosal infection and vaccination against feline immunodeficiency virus

1 reference

12 December 2020

Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function

1 reference

12 December 2020

Rheumatic symptoms and human immunodeficiency virus infection. The influence of clinical and laboratory variables in a longitudinal cohort study

1 reference

12 December 2020

Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but does not protect against rectal FIV challenge

1 reference

12 December 2020

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines

1 reference

12 December 2020

Perspectives on FIV vaccine development

1 reference

12 December 2020

Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.

1 reference

12 December 2020

Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage

1 reference

12 December 2020

Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees

1 reference

12 December 2020

Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus

1 reference

12 December 2020

Enhancement after feline immunodeficiency virus vaccination

1 reference

12 December 2020

Evaluation of HIV type 1 group O isolates: identification of five phylogenetic clusters

1 reference

12 December 2020

Monoclonal antibodies to immunodominant and neutralizing domains of the envelope surface protein of feline immunodeficiency virus

1 reference

12 December 2020

Cross virus neutralizing antibodies against feline immunodeficiency virus genotypes A, B, C, D and E.

1 reference

12 December 2020

Molecular analysis of tumours from feline immunodeficiency virus (FIV)-infected cats: an indirect role for FIV?

1 reference

12 December 2020

Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins

1 reference

12 December 2020

Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus

1 reference

12 December 2020

Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.

1 reference

12 December 2020

Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection

1 reference

12 December 2020

Feline immunodeficiency virus infection in cats of Japan

1 reference

12 December 2020

In vivo lymphocyte tropism of feline immunodeficiency virus

1 reference

12 December 2020

Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus

1 reference

12 December 2020

Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission.

1 reference

12 December 2020

DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies

1 reference

12 December 2020

Recombinant vaccine technology in veterinary medicine.

1 reference

12 December 2020

Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats

1 reference

12 December 2020

T cells overexpressing interferon-gamma and interleukin-10 are found in both the thymus and secondary lymphoid tissues of feline immunodeficiency virus-infected cats

1 reference

12 December 2020

Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats

1 reference

12 December 2020

Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions

1 reference

12 December 2020

Progressive immune dysfunction in cats experimentally infected with feline immunodeficiency virus

1 reference

12 December 2020

Decline in CD4+ cell numbers in cats with naturally acquired feline immunodeficiency virus infection

1 reference

12 December 2020

Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression

1 reference

12 December 2020

Attempt to modify the immune response developed against FIV gp120 protein by preliminary FIV DNA injection

1 reference

12 December 2020

Vaccination of cats against feline immunodeficiency virus (FIV): a matter of challenge

1 reference

12 December 2020

Marek's disease: an update on oncogenic mechanisms and control

1 reference

12 December 2020

Evaluation of risks and benefits associated with vaccination against coronavirus infections in cats

1 reference

12 December 2020

Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections

1 reference

12 December 2020

Anti-feline immunodeficiency virus (FIV) soluble factor(s) produced from antigen-stimulated feline CD8(+) T lymphocytes suppresses FIV replication

1 reference

12 December 2020

Quantification of feline immunodeficiency virus (FIV) RNA in the plasma of infected cats

1 reference

12 December 2020

Efficacy of an inactivated feline leukemia virus vaccine

1 reference

12 December 2020

Anti-cell antibody in macaques

1 reference

12 December 2020

Marek's disease vaccines

1 reference

12 December 2020

AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens

1 reference

12 December 2020

Viral vectors as potential HIV-1 vaccines

1 reference

12 December 2020

Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection

1 reference

12 December 2020

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

1 reference

12 December 2020

Feline immunodeficiency virus infection: an overview

1 reference

12 December 2020

Accelerated viraemia in cats vaccinated with fixed autologous FIV-infected cells

1 reference

12 December 2020

Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades

1 reference

12 December 2020

Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif

1 reference

12 December 2020

Postvaccinal sarcomas in the cat: histology and immunohistochemistry

1 reference

12 December 2020

Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences

1 reference

12 December 2020

Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure

1 reference

12 December 2020

AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free

1 reference

12 December 2020

Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus.

1 reference

12 December 2020

Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes

1 reference

12 December 2020

Comparison of six in-house tests for the rapid diagnosis of feline immunodeficiency and feline leukaemia virus infections

1 reference

12 December 2020

Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines

1 reference

12 December 2020

Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats

1 reference

12 December 2020

Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies

1 reference

12 December 2020

Humoral immune response to T cell dependent and independent antigens in cats infected with feline immunodeficiency virus

1 reference

12 December 2020

Reference preparations in the standardisation of HIV-1 PCR--an international collaborative study

1 reference

12 December 2020

Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope

1 reference

12 December 2020

Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.

1 reference

12 December 2020

Macaque models for AIDS vaccine development

1 reference

12 December 2020

Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

1 reference

12 December 2020

Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats

1 reference

12 December 2020

Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections

1 reference

12 December 2020

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

1 reference

12 December 2020

Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.

1 reference

12 December 2020

Rational development of prophylactic HIV vaccines based on structural and regulatory proteins

1 reference

12 December 2020

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

12 December 2020

Feline leukaemia virus: a review of immunity and vaccination

1 reference

12 December 2020

Early cytokine and chemokine gene expression in lymph nodes of macaques infected with simian immunodeficiency virus is predictive of disease outcome and vaccine efficacy

1 reference

12 December 2020

Cats are protected against feline immunodeficiency virus infection following vaccination with a homologous AP-1 binding site-deleted mutant

1 reference

12 December 2020

Protection against feline infectious peritonitis by intranasal inoculation of a temperature-sensitive FIPV vaccine

1 reference

12 December 2020

10.1016/S0165-2427(02)00227-1

Identifiers

DOI

1 reference

2 August 2017

0 references

1 reference